The trajectory of Viagra presents a nuanced case for observers in the drug sector. While initially a tremendous success, producing huge profits, the exclusivity end and the subsequent arrival of generic versions have drastically changed revenue. This raises questions about the ongoing sustainability of related therapeutic developments and sugges… Read More